Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Alexandria Venture Investments

Alexandria Venture Investments
VC INVESTOR TYPE
Active STATUS
11 PROFESSIONALS
200 INVESTMENTS
93 PORTFOLIO
55 EXITS
Description

Alexandria Venture Investments is the strategic venture capital arm of Alexandria Real Estate Equities. It provides long-term strategic investment capital to innovative life science, technology, and agtech entities developing breakthrough technologies and therapies.

Investor Status
Actively Seeking New Investments
Year Founded
1996
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Growth/Expansion
Venture Capital
Primary Office
  • 26 North Euclid Avenue
  • Suite 299
  • Pasadena, CA 91101
  • United States

+1 (626) 000-0000

Alexandria Venture Investments Investments (200)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Jasper Therapeutics 06-Dec-2019 Early Stage VC 0000 Drug Discovery Generating Revenue
0000000 0000000000 04-Dec-2019 00000 00000 0000 Biotechnology Startup
00000000 000000 21-Nov-2019 00000 00000 0000 Diagnostic Equipment Generating Revenue/Not Profitable
0000000 0000000000 13-Nov-2019 00000 00000 00000 Drug Discovery Generating Revenue
0000000 0000000000 21-Oct-2019 00000 00000 0000 Biotechnology Generating Revenue
00000000 00000 000 07-Oct-2019 00000 00000 00.000 Biotechnology Clinical Trials - Phase 1
000000000 00000000 30-Sep-2019 00000 00000 0000 Biotechnology Startup
000000000 000 19-Sep-2019 00000 00000 000.00 Biotechnology Generating Revenue
Molecular Assemblies 01-Aug-2019 Later Stage VC 000.00 Biotechnology Startup
X-Vax Technology 18-Jul-2019 Early Stage VC 000.00 Drug Discovery Clinical Trials - Phase 1
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Alexandria Venture Investments’s full profile, request a free trial.

Alexandria Venture Investments Exits (54)

Company Name Exit Date Exit Type Exit Size Status Buyers
Frequency Therapeutics 03-Oct-2019 IPO 0000 Completed
000000 00000000000 28-Jun-2019 000 00000 Completed
00000000 000000000 27-Jun-2019 000 00000 Completed
0000000 0000000000 20-Jun-2019 000 00000 Completed
00000 000000000000 19-Jun-2019 000 00000 Completed
000000 00000000000 23-May-2019 000 0000 Completed
0000000 0000000000 14-May-2019 000 0000 Completed
00000000 09-May-2019 000 0000 Completed
AgTech Accelerator 01-Apr-2019 Merger/Acquisition Completed
Precision BioSciences 28-Mar-2019 IPO 00000 Completed
To view this investor’s complete exits history, request access »

Alexandria Venture Investments Team (17)

Name Title Deals Funds Boards Office Contact
Info
Monica Beam Ph.D Senior Vice President 0 0 Pasadena, CA
Christopher Otey Senior Vice President, Science & Technology 0 0 Boston, MA
Jenna Foger Senior Vice President, Science & Technology 0 0 Pasadena, CA
Aaron Jacobson Vice President of Corporate Counsel Pasadena, CA
Catherine Nuccio Associate 0 Boston, MA

2 Former Team Members

You’re viewing 5 of 17 team members. Get the full list »

Alexandria Venture Investments Co-Investors (453)

Name With Exits Lead Partner
ARCH Venture Partners 24 0 0
GV 00 0 0
Pfizer Ventures 00 0 0
AbbVie Ventures 00 0 0
Polaris Partners 00 0 0
To view this investor’s complete co-investor history, request access »